Lantern Pharma’s Promising Phase II Lung Cancer Study: Key Insights for Investors

1 month ago 32

Lantern Pharma, Inc. (($LTRN)) announced an update on their ongoing clinical study. Lantern Pharma, Inc. is conducting a clinical study titled ‘Phase II Trial of LP...

1. Homepage
2. Lung Cancer
3. Lantern Pharma’s Promising Phase II Lung Cancer Study: Key Insights for Investors